Alfresa Holdings Corporation (ALFRY)
ValueMarkers Composite Index
39% below intrinsic value ($27)
Alfresa Holdings Corporation (ALFRY) — VMCI valuation read
ALFRY prints VMCI 52/100 inside the Healthcare sector, where the median sits at 50. The 2-point above-median delta is the cleanest single-number summary of Alfresa Holdings Corporation's composite stance, and in the mid-cap bucket it places the share ahead of the typical peer on the five-pillar mix.
On ALFRY, the SEC EDGAR Form 4 stream shows no insider buys or sells in the past 30 days. Quiet tapes happen; they just remove a signal that bull and bear cases sometimes lean on for confirmation.
**Investor frame.** ALFRY trades at 26.0x earnings, 44% above the Healthcare median of 18.0x; that is the value line. ROIC of 14.0% sits 4.0pp above the Healthcare median (10.0%); that is the quality line. net debt to EBITDA of 1.8x is the rate-sensitivity line to watch; that is the risk line for Alfresa Holdings Corporation on the trailing financials.
ALFRY rose 2.4% over the trailing 7 days, with a -6.9% read on a 30-day basis.
Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related activities. Alfresa Holdings Corporation was incorporated in 2003 and is based in Tokyo, Japan.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.